Literature DB >> 23449269

Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season.

H Keipp Talbot1, Yuwei Zhu, Qingxia Chen, John V Williams, Mark G Thompson, Marie R Griffin.   

Abstract

During the 2011-2012 influenza season, we enrolled hospitalized adults with acute respiratory illness and tested each for influenza using reverse transcription polymerase chain reaction. Influenza vaccination was verified in 35% (6/17) of adults with influenza-associated hospitalizations compared to 64% (97/152) of test-negative controls; adjusted vaccine effectiveness was 71.4% (95% confidence interval, 17.1%-94.9%).

Entities:  

Keywords:  effectiveness; influenza vaccine; older adults

Mesh：

Substances：

Year:  2013        PMID： 23449269     DOI： 10.1093/cid/cit124

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  34 in total

1.  Mandatory vaccination.

Authors:  Michael Gardam; Camille Lemieux
Journal:  CMAJ       Date:  2013-08-06       Impact factor: 8.262

2.  Mandatory vaccination.

Authors:  Paul G Van Buynder; Elizabeth Bryce; Bonnie Henry; Perry R Kendall
Journal:  CMAJ       Date:  2013-08-06       Impact factor: 8.262

3.  Too many covariates and too few cases? - a comparative study.

Authors:  Qingxia Chen; Hui Nian; Yuwei Zhu; H Keipp Talbot; Marie R Griffin; Frank E Harrell
Journal:  Stat Med       Date:  2016-06-30       Impact factor: 2.373

4.  Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

Authors:  Jill M Ferdinands; Manjusha Gaglani; Emily T Martin; Don Middleton; Arnold S Monto; Kempapura Murthy; Fernanda P Silveira; H Keipp Talbot; Richard Zimmerman; Elif Alyanak; Courtney Strickland; Sarah Spencer; Alicia M Fry
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

5.  Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.

Authors:  Shuo Feng; Benjamin J Cowling; Sheena G Sullivan
Journal:  Vaccine       Date:  2016-02-23       Impact factor: 3.641

Review 6.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

7.  Effects of Anti- Versus Pro-Vaccine Narratives on Responses by Recipients Varying in Numeracy: A Cross-sectional Survey-Based Experiment.

Authors:  Wändi Bruine de Bruin; Annika Wallin; Andrew M Parker; JoNell Strough; Janel Hanmer
Journal:  Med Decis Making       Date:  2017-05-05       Impact factor: 2.583

8.  Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.

Authors:  Carlos G Grijalva; Yuwei Zhu; Derek J Williams; Wesley H Self; Krow Ampofo; Andrew T Pavia; Chris R Stockmann; Jonathan McCullers; Sandra R Arnold; Richard G Wunderink; Evan J Anderson; Stephen Lindstrom; Alicia M Fry; Ivo M Foppa; Lyn Finelli; Anna M Bramley; Seema Jain; Marie R Griffin; Kathryn M Edwards
Journal:  JAMA       Date:  2015-10-13       Impact factor: 56.272

9.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

10.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.